Would you volunteer to be deliberately infected with COVID-19? It's a question some people are seriously considering. In an effort to speed up the development of a vaccine, 1 Day Sooner is asking volunteers to sign up for human challenge trials that will expose them to the virus in an effort to study the disease and develop a cure. 

Josh Morrison, the co-founder of 1 Day Sooner, told Cheddar Wednesday that these human challenges have been used to study other diseases in the past, including malaria, typhoid, and cholera.

"The drug Tamiflu, for example, was developed with challenge trials, as well as the malaria vaccine RTS,S that's being deployed in Africa right now," he said. "You can find out much more quickly whether a vaccine might work, than a traditional trial which might have thousands or even tens of thousands of volunteers." 

The National Institutes of Health and the World Health Organization have shown interest in the human challenge trials, according to Morrison. The WHO recently published an ethics report to which the 1 Day Sooner team offered suggestions, though they were not accepted for the publication. 

Morrison said that there has been growing interest in the trials, adding, "It's not universal acclaim or an immediate 'we need challenge trials right away from every possible corner,' but the message today is immensely different, immensely more positive than what the public message was a month ago."

He acknowledged that the risk of injecting people with COVID-19 could be deadly, but he said he believes that the potential value of finding a vaccine from these challenges is worth it. 

"If you look at the risks of getting COVID-19 for the young, healthy group that would participate in challenge trials, they're roughly on a par with childbirth or with kidney donation. So, again, significant risk and we're not understating that, but these are risks that we commonly allow people to accept normally, and given the tremendous possible value we think it's worth accepting them in this case," the 1 Day Sooner co-founder said. 

Share:
More In Science
Artechouse's Newest Exhibition Uses Latest NASA Images
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Report: Shortage of Cancer Drugs
A report said that cancer centers are dealing with shortages of carboplatin and cisplatin, drugs that are used to treat cancers.
Health Expert Offers Tips for Coping with Poor Air Quality
With large swaths of the East Coast blanketed with smog, many are worried about their health. Mangala Narasimhan, director of critical care services at Northwell Health, offers some peace of mind with a handful of expert tips for coping with poor air quality. 
Hawaii's Kilauea Begins Erupting After 3-Month Pause
Kilauea, one of the most active volcanoes in the world, began erupting on Wednesday after a three-month pause, displaying spectacular fountains of mesmerizing, glowing lava that's a safe distance from people and structures in a national park on the Big Island.
Load More